Citadel Advisors’s Pulmatrix PULM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,342
Closed -$22.1K 15204
2024
Q3
$22.1K Buy
+10,342
New +$21.7K ﹤0.01% 12705
2023
Q2
Sell
-15,174
Closed -$44.8K 15059
2023
Q1
$44.8K Buy
+15,174
New +$54.9K ﹤0.01% 12304
2022
Q3
Sell
-30,628
Closed -$141K 13405
2022
Q2
$141K Buy
+30,628
New +$162K ﹤0.01% 11049
2021
Q4
Sell
-2,128
Closed -$34K 14548
2021
Q3
$34K Buy
+2,128
New +$35.5K ﹤0.01% 13528
2021
Q2
Sell
-1,769
Closed -$47K 14264
2021
Q1
$47K Buy
+1,769
New +$54.2K ﹤0.01% 12928
2019
Q4
Sell
-1,874
Closed -$31K 9615
2019
Q3
$31K Buy
+1,874
New +$32.8K ﹤0.01% 8841
2019
Q2
Sell
-1,715
Closed -$44K 9718
2019
Q1
$44K Buy
1,715
+1,387
+423% +$46.4K ﹤0.01% 8873
2018
Q4
$16K Sell
328
-46
-12% -$3.39K ﹤0.01% 8820
2018
Q3
$28K Buy
+374
New +$31.7K ﹤0.01% 8948
2018
Q2
Sell
-322
Closed -$33K 9190
2018
Q1
$33K Buy
+322
New +$92.4K ﹤0.01% 8030

Other funds holding PULM

Citadel Advisors's PULM Position: Q4 2024 in Review

Citadel Advisors sold out of Pulmatrix (PULM) in Q4 2024, closing a stake of 10,342 shares — an estimated $22.1K sold.

Citadel Advisors first reported a position in PULM in Q1 2018 and held it in 10 quarters. The position peaked at $141K in Q2 2022. 11 funds tracked by Wall St. Rank hold PULM as of Q4 2024.

  • Citadel Advisors reported no remaining Pulmatrix position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 10,342 Pulmatrix shares in Q4 2024, an estimated $22.1K.
  • Citadel Advisors first reported a position in Pulmatrix in Q1 2018 and held it in 10 quarters.
  • Citadel Advisors's Pulmatrix position peaked at $141K in Q2 2022.
  • 11 funds tracked by Wall St. Rank held Pulmatrix as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.